Skip to main content

Market Overview

38 Healthcare Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • Sol-Gel Technologies, Inc. (NASDAQ: SLGL) shares moved upwards by 154.6% to $23.50 during Monday's pre-market session.
  • Savara, Inc. (NASDAQ: SVRA) stock rose 40.5% to $2.43.
  • KemPharm, Inc. (NASDAQ: KMPH) shares increased by 18.8% to $0.50. The most recent rating by H.C. Wainwright, on November 20, is at Buy, with a price target of $2.50.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) stock moved upwards by 18.0% to $6.15.
  • Capricor Therapeutics, Inc. (NASDAQ: CAPR) stock rose 12.0% to $1.31.
  • Guardion Health Sciences, Inc. (NASDAQ: GHSI) shares surged 9.5% to $0.23.
  • InVivo Therapeutics Hldg, Inc. (NASDAQ: NVIV) shares increased by 8.9% to $0.20.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) shares moved upwards by 8.7% to $0.45.
  • Myriad Genetics, Inc. (NASDAQ: MYGN) shares increased by 8.3% to $29.00.
  • Genprex, Inc. (NASDAQ: GNPX) shares rose 8.1% to $0.29.
  • Brickell Biotech, Inc. (NASDAQ: BBI) shares increased by 7.1% to $1.65.
  • Avita Medical, Inc. (NASDAQ: RCEL) shares moved upwards by 5.8% to $9.45.
  • Check-Cap, Inc. (NASDAQ: CHEK) stock moved upwards by 5.7% to $1.85.
  • Bionano Genomics, Inc. (NASDAQ: BNGO) stock moved upwards by 4.6% to $1.13.
  • Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) shares surged 4.5% to $0.18. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
  • Advaxis, Inc. (NASDAQ: ADXS) shares increased by 4.3% to $0.85.
  • Spring Bank, Inc. (NASDAQ: SBPH) stock increased by 3.6% to $1.31. The most recent rating by B. Riley FBR, on December 30, is at Neutral, with a price target of $2.00.
  • Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) stock surged 3.5% to $2.35. The most recent rating by Oppenheimer, on December 20, is at Outperform, with a price target of $6.00.
  • Solid Biosciences, Inc. (NASDAQ: SLDB) stock moved upwards by 3.5% to $4.43. The most recent rating by Nomura, on December 19, is at Buy, with a price target of $10.00.
  • Ocugen, Inc. (NASDAQ: OCGN) stock surged 3.5% to $0.41. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
  • Viveve Medical, Inc. (NASDAQ: VIVE) stock moved upwards by 3.4% to $0.93. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
  • Durect, Inc. (NASDAQ: DRRX) stock increased by 3.4% to $3.37. The most recent rating by Cantor Fitzgerald, on November 18, is at Overweight, with a price target of $5.00.
  • Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares moved upwards by 3.2% to $105.21. The most recent rating by Guggenheim, on December 16, is at Buy, with a price target of $158.00.
  • Achieve Life Sciences, Inc. (NASDAQ: ACHV) shares moved upwards by 2.8% to $0.55.
  • Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) shares rose 2.3% to $3.62. The most recent rating by B. Riley FBR, on December 27, is at Buy, with a price target of $11.00.

 

Losers

  • WAVE Life Sciences, Inc. (NASDAQ: WVE) shares decreased by 32.6% to $10.65 during Monday's pre-market session. The most recent rating by SunTrust Robinson Humphrey, on December 17, is at Buy, with a price target of $27.00.
  • ContraFect, Inc. (NASDAQ: CFRX) stock fell 7.2% to $0.61.
  • NewLink Genetics, Inc. (NASDAQ: NLNK) stock decreased by 6.1% to $2.60.
  • Iterum Therapeutics, Inc. (NASDAQ: ITRM) stock fell 5.0% to $4.51. The most recent rating by RBC Capital, on December 11, is at Outperform, with a price target of $10.00.
  • Mereo BioPharma Group, Inc. (NASDAQ: MREO) shares declined 3.4% to $2.85.
  • vTv Therapeutics, Inc. (NASDAQ: VTVT) shares decreased by 3.4% to $1.73.
  • Rite Aid, Inc. (NYSE: RAD) shares declined 3.0% to $19.65.
  • Assertio Therapeutics, Inc. (NASDAQ: ASRT) shares plummeted 2.9% to $1.35.
  • Agile Therapeutics, Inc. (NASDAQ: AGRX) shares decreased by 2.9% to $2.36.
  • Proteostasis Therapeutics, Inc. (NASDAQ: PTI) shares fell 2.7% to $2.17.
  • Aurora Cannabis, Inc. (NYSE: ACB) shares declined 1.8% to $1.88. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
  • Fresenius Medical Care, Inc. (NYSE: FMS) shares decreased by 1.6% to $36.81. According to the most recent rating by Redburn, on October 23, the current rating is at Neutral.
  • Biocept, Inc. (NASDAQ: BIOC) stock plummeted 1.4% to $0.25.
 

Related Articles (ACB + ACHV)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com